Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BY-NC-NDAmerican heart journal plus : cardiology research and practice

Dynamic change in soluble suppressor of tumorigenicity 2 (sST2) during acute decompensated heart failure with a reduced ejection fraction, and its mortality implications

  • Brian Li1
  • Michaela Dowley1
  • Samantha Langley1
  • Paraic Cliffe1
  • Stephen Whiting1
  • Archana Ganapathy1
  • Anthony D. Dimarco1
  • Rossella Barbagallo1
  • Jason N. Dungu1
  • Henry Oluwasefunmi Savage1
  1. 1Mid and South Essex NHS Foundation Trust, United Kingdom
Read full textPDFCite

Related

  1. The Role of Soluble Suppression of Tumorigenicity-2 and Galectin-3 in Heart Failure With Preserved Ejection Fraction: A Scoping Review of the Literature
    Konstantina Ntalekou, Panagiotis Iliakis, Nikitas Katsillis +6
    Reviews in cardiovascular medicinePeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  2. Effects of N-Acetylcysteine and Glycine Administration on Serum Levels of Soluble Suppressor of Tumorigenicity 2 and Cardiac Morphological Characteristics in an Animal Model of Streptozotocin-Induced Diabetes.
    Malik Ejubović, Radivoj Jadrić, Sabaheta Hasić +7
    Pathophysiology : the official journal of the International Society for PathophysiologyPeer-reviewedCC BYFull textCardiovascular medicineEurope PMC
  3. Glycyrrhizin-Induced Pseudoaldosteronism Contributing to Decompensated Heart Failure With Preserved Ejection Fraction.
    Satoshi Kurisu, Hitoshi Fujiwara
    CureusPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Advancing Heart Failure Classification Beyond Left Ventricular Ejection Fraction: Unsupervised Machine Learning Insights From the Japanese Nationwide Acute Decompensated Heart Failure Cohort: JROADHF
    Atsushi Kyodo, Yasuki Nakada, Kazutaka Nogi +7
    Journal of the American Heart AssociationPeer-reviewedCC BY-NC-NDCardiovascular medicineCrossref
  5. Association of Baseline and Serial High-Sensitivity Cardiac Troponin T with In-Hospital Mortality Across Clinical Presentation, LVEF and Diabetes Status in Decompensated Heart Failure
    Mara Diaconu, Dan-Cristian Popescu, Diana Țînț +1
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{li2026dynamic,
  title = {{Dynamic change in soluble suppressor of tumorigenicity 2 (sST2) during acute decompensated heart failure with a reduced ejection fraction, and its mortality implications}},
  author = {Brian Li and Michaela Dowley and Samantha Langley and Paraic Cliffe and Stephen Whiting and Archana Ganapathy and Anthony D. Dimarco and Rossella Barbagallo and Jason N. Dungu and Henry Oluwasefunmi Savage},
  journal = {American heart journal plus : cardiology research and practice},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13677174},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Dynamic change in soluble suppressor of tumorigenicity 2 (sST2) during acute decompensated heart failure with a reduced ejection fraction, and its mortality implications
AU  - Brian Li
AU  - Michaela Dowley
AU  - Samantha Langley
AU  - Paraic Cliffe
AU  - Stephen Whiting
AU  - Archana Ganapathy
AU  - Anthony D. Dimarco
AU  - Rossella Barbagallo
AU  - Jason N. Dungu
AU  - Henry Oluwasefunmi Savage
PY  - 2026
DA  - 2026/10/07
JO  - American heart journal plus : cardiology research and practice
UR  - https://europepmc.org/article/PMC/PMC13677174
SN  - 2666-6022
ER  -